What is the recommended management of infective endocarditis, including empiric intravenous antibiotic regimen, treatment duration, and indications for early cardiac surgery?

Management of Infective Endocarditis

For empiric therapy in acute severely ill patients with suspected infective endocarditis, start ampicillin + (flu)cloxacillin/oxacillin + gentamicin for community-acquired native valve endocarditis, or vancomycin + gentamicin + rifampin for early prosthetic valve endocarditis (<12 months post-surgery) or healthcare-associated cases, while obtaining three sets of blood cultures at 30-minute intervals before initiating antibiotics. 1

Empiric Antibiotic Therapy

The initial empiric regimen depends critically on three factors:

Community-Acquired Native Valve or Late Prosthetic Valve Endocarditis (≥12 months post-surgery)

• Ampicillin 12 g/day IV in 4-6 doses
• (Flu)cloxacillin or oxacillin 12 g/day IV in 4-6 doses
• Gentamicin 3 mg/kg/day IV or IM in 1 dose 1

For penicillin-allergic patients, substitute vancomycin 30-60 mg/kg/day IV in 2-3 doses plus gentamicin 1

Early Prosthetic Valve Endocarditis (<12 months) or Healthcare-Associated Endocarditis

• Vancomycin 30 mg/kg/day IV in 2 doses
• Gentamicin 3 mg/kg/day IV or IM in 1 dose
• Rifampin 900-1200 mg IV or orally in 2-3 divided doses (start 3-5 days after vancomycin/gentamicin) 1

Critical pitfall: In healthcare-associated native valve endocarditis in settings with MRSA prevalence >5%, some experts recommend combining cloxacillin plus vancomycin until final S. aureus identification 1

Pathogen-Specific Treatment Duration

Staphylococcal Endocarditis

Native Valve:

• Methicillin-susceptible: (Flu)cloxacillin or oxacillin 12 g/day IV for 4-6 weeks 1
• Methicillin-resistant or penicillin-allergic: Vancomycin 30-60 mg/kg/day IV for 4-6 weeks 2, 1
• Alternative: Daptomycin 10 mg/kg/day IV once daily for 4-6 weeks (superior to vancomycin for MRSA with vancomycin MIC >1 mg/L) 1

Important: Do NOT add gentamicin for native valve staphylococcal endocarditis—clinical benefit has not been demonstrated and renal toxicity increases 1

Prosthetic Valve:

• (Flu)cloxacillin or oxacillin 12 g/day IV for ≥6 weeks
• Plus rifampin 900-1200 mg in 2-3 divided doses for ≥6 weeks (start 3-5 days after initial antibiotics)
• Plus gentamicin 3 mg/kg/day for 2 weeks only 1, 3

Streptococcal Endocarditis

• Penicillin G or ceftriaxone for 4 weeks (native valve) 2
• 6 weeks for prosthetic valve endocarditis 2

Enterococcal Endocarditis

• Ampicillin (or amoxicillin) 12 g/day IV plus gentamicin 3 mg/kg/day for 4-6 weeks 1
• Critical: If high-level aminoglycoside resistance (MIC >500 mg/L), do NOT use gentamicin—consider streptomycin as alternative 1

Blood Culture-Negative Endocarditis

Requires consultation with infectious disease specialist. Specific regimens vary by suspected pathogen:

• Bartonella: Doxycycline 100 mg q12h orally for 4 weeks plus gentamicin 3 mg/kg/day IV for 2 weeks 1
• Coxiella burnetii (Q fever): Doxycycline 200 mg/24h plus hydroxychloroquine 200-600 mg/24h orally for >18 months 1

Indications for Early Cardiac Surgery

Surgery is one of the most important protective factors against mortality in infective endocarditis. 4 The worse prognosis occurs in patients with surgical indications who do NOT undergo surgery 4.

Emergency Surgery (within 24 hours)

• Severe acute regurgitation, obstruction, or fistula causing refractory pulmonary edema or cardiogenic shock 1

Urgent Surgery (within 3-5 days)

• Heart failure: Severe regurgitation or obstruction causing HF symptoms or poor hemodynamic tolerance on echo 1
• Uncontrolled infection: Abscess, false aneurysm, fistula, or enlarging vegetation 1
• Persistent bacteremia despite appropriate antibiotics and adequate control of septic foci 1
• Prevention of embolism: Vegetation >10 mm after one or more embolic episodes despite appropriate antibiotics 1
• Fungal endocarditis or multiresistant organisms 1
• Prosthetic valve endocarditis caused by staphylococci or non-HACEK gram-negative bacteria 1

Post-Stroke Considerations

Embolic (ischemic) stroke should NOT delay surgery once an indication is identified. In hemorrhagic stroke, surgery might be delayed up to 4 weeks depending on clinical condition 4

Key Management Principles

Multidisciplinary Endocarditis Team

All patients with complicated IE should be managed by a specialized Endocarditis Team to improve diagnosis, optimize treatment, and enhance outcomes 5, 6, 4. This approach has demonstrated improved survival and appropriate surgical referral 6.

Aminoglycoside Use

• Administer once daily dosing 3
• Limit duration to ≤2 weeks maximum 3
• Monitor renal function closely

Oral Switch Therapy

Select post-surgical IE patients treated with adequate IV antibiotics >7 days after surgery may transition to oral therapy based on strict clinical criteria 3, 4. This applies to stabilized, uncomplicated cases 5.

Common Pitfalls

• Starting rifampin too early in staphylococcal prosthetic valve endocarditis—wait 3-5 days to clear bacteremia first 1
• Using gentamicin for native valve staphylococcal endocarditis—increases toxicity without benefit 1
• Delaying surgery in patients with clear indications—mortality increases with delayed intervention 4
• Missing high-level aminoglycoside resistance in enterococcal endocarditis—renders gentamicin ineffective 1